AUAnna A. Uspenskaya

Anna A. Uspenskaya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna A. Uspenskaya has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Treatment of nodular goiter with compression of the neck organs in a step-by-step manner: sclerotherapy, radiofrequency ablation

    by G. T. Gumerova, A. F. Fazlieva, S. P. Klimets, N. S. Suleymanova, A. I. Ishbulatova, I. V. Asfandiyarova, A. D. Neryakhin, V. A. Makariin, A. A. Uspenskaya

    As a rule, patients with a multi-nodular goiter are not regularly observed by doctors, the reason for seeking medical help is the presence of a growing formation on the neck or the development of compression syndrome. More often, such patients are referred for surgical treatment, namely for hemi- or total thyroidectomy. This study presents a clinical case of non-surgical treatment in stages using ethanol sclerase therapy and radiofrequency ablation (RFA), which allowed the organ to be preserved, while achieving the necessary cosmetic effect, there is no damage to surrounding tissues and organs. The combined treatment of diffuse nodular goiter made it possible to reduce the size of the neoplasm by 21 times from the initial one during the treatment period from 2019 to 2021, eliminated the cosmetic defect and compression syndrome. Sclerotherapy and RFA can act as an alternative to surgical methods, but without scarring of the neck. Interventional methods are effective in the treatment of thyroid nodules, including large ones.

  • Open Access

    TSH secreting pituitary tumor — an experience of 20 years follow-up

    by Дина Владимировна Реброва, Ilya V. Sleptsov, Роман Анатольевич Черников, Anna A. Uspenskaya, Владимир Федорович Русаков, Леонид Михайлович Краснов, Елисей Александрович Федоров, Илья Владимирович Саблин, Maria Isheyskaya, Irina V. Olovyanishnikova, et al.

    Thyrotropinoma is a rare pituitary tumor that causes the development of thyrotoxicosis syndrome as a result of hyperproduction of thyroid stimulating hormone (TSH). In the Russian literature over the past 10 years, one case of thyrotropinoma in a child, four cases of TSH-producing pituitary adenoma in women and only one in a man have been described. The article presents a unique clinical case of a 20-years history of observation of a patient with TSH-oma. The rarity of this disease led to the fact that it took more than 10 years to make a correct diagnosis. The first operation of thyroid gland was performed before the diagnosis of pituitary adenoma and inappropriate TSH secretion syndrome. That right hemithyroidectomy was supposed to cure a toxic adenoma of thyroid gland. The diagnosis of thyrotropin-secreting piruitary tumor was established only after 6 years even after finding a combination of pituitary adenoma and thyrotoxicosis. After that, the patient steadfastly refuses neurosurgical treatment, despite the presence of macroadenoma with intrasellar growth. The therapy with somatostatin analogs led to patient’s intolerance with gastrointestinal side effects and hospitalization for acute pancreatitis. The absence of the therapy due to low compliance led to long-term persistence of thyrotoxicosis. The absence of signs and symptoms of expanding tumor mass (visual field defects, loss of vision, headache, partial or total hypopituitarism) demonstrates the slow growth of this kind of pituitary tumor. The long-term effect of elevated TSH levels led to diffuse goiter with compression of the neck organs, and the need of the surgical treatment of the thyroid. Stable euthyroidism after the operation led to stable normoglycemia in the patient with previously diagnosed diabetes mellitus type 2. This fact should keep an attention of physicians and endocrinologists to screen for the secondary reasons of hyperglycemia in a patient with diabetes mellitus manifestation. Long-term history of thyrotoxicosis led to the deleterious effects of thyroid hormone excess on the heart (atrial fibrillation, cardiomyopathy, cardiac failure). Those effects are still observed even after thyroidectomy and medical euthyroidism achievement. This fact demonstrates the importance of early diagnosis and treatment of TSH-omas.